Hepatic nuclear factor 3 and high mobility group I/Y proteins bind the insulin response element of the insulin-like growth factor-binding protein-1 promoter.
The insulin response element (IRE) of the human insulin-like growth factor-binding protein-1 (IGFBP-1) promoter contains a palindrome of the T(A/G)TTT sequence crucial to hormonal regulation of many genes. In initial studies of how this IRE participates in hormonal regulation, the electromobility shift assay was used under a variety of conditions to identify IRE-binding proteins. An exhaustive search identified five proteins that specifically bind this IRE; purified proteins were used to show that all five are related to either the high mobility group I/Y (HMGI/Y) or hepatic nuclear factor 3 (HNF3) protein families. Further studies used purified HNF3 and HMGI proteins to show: 1) eah protects the IGFBP-1 IRE from deoxyribonuclease I (DNaseI) digestion; and 2) HNF3 but not HMGI/Y binds to the related phosphoenolpyruvate carboxykinase and Apo CIII IREs. A series of IRE mutants with variable responsiveness to insulin were used to show that the presence of a TGTTT sequence in the mutants did parallel, but HMGI/Y and HNF3 binding to the mutants did not parallel, the ability of the mutants to confer the inhibitory effect of insulin. In contrast, HNF3 binding to these IRE mutants roughly correlates with response of the mutants to glucocorticoids. The way by which HNF3 and/or other as yet unidentified IRE-binding proteins confer insulin inhibition to IGFBP-1 transcription and the role of HMGI/Y in IRE function have yet to be established.
Allander
S V
SV
Department of Clinical Genetics, Karolinska Institute, Stockholm, Sweden.
Durham
S K
SK
Scheimann
A O
AO
Wasserman
R M
RM
Suwanichkul
A
A
Powell
D R
DR
D001483:Base Sequence; D006528:Carcinoma, Hepatocellular / Q000737:chemistry / Q000473:pathology; D004247:DNA / Q000032:analysis / Q000737:chemistry / Q000235:genetics; D004268:DNA-Binding Proteins / Q000032:analysis / Q000378:metabolism*; D025741:HMGA1a Protein; D051541:Hepatocyte Nuclear Factor 3-alpha; D006609:High Mobility Group Proteins / Q000032:analysis / Q000378:metabolism*; D006801:Humans; D007328:Insulin / Q000494:pharmacology; D018970:Insulin-Like Growth Factor Binding Protein 1 / Q000032:analysis / Q000235:genetics*; D008113:Liver Neoplasms / Q000737:chemistry / Q000473:pathology; D009154:Mutation; D009687:Nuclear Proteins / Q000032:analysis / Q000378:metabolism*; D009841:Oligonucleotides / Q000032:analysis / Q000737:chemistry / Q000235:genetics; D011401:Promoter Regions, Genetic / Q000235:genetics*; D011485:Protein Binding; D014157:Transcription Factors; D014162:Transfection; D014407:Tumor Cells, Cultured
D004268:DNA-Binding Proteins; C496499:FOXA1 protein, human; D051541:Hepatocyte Nuclear Factor 3-alpha; D006609:High Mobility Group Proteins; D007328:Insulin; D018970:Insulin-Like Growth Factor Binding Protein 1; D009687:Nuclear Proteins; D009841:Oligonucleotides; D014157:Transcription Factors; D025741:HMGA1a Protein; D004247:DNA